Bachet J, Termignon J L, Goudot B, Dreyfus G, Piquois A, Brodaty D, Dubois C, Delentdecker P, Guilmet D
Service de Chirurgie Cardio-Vasculaire, Hôpital Foch, Universite Rene Descartes, Suresnes, France.
Eur J Cardiothorac Surg. 1996;10(3):207-13. doi: 10.1016/s1010-7940(96)80298-3.
From April 73 to June 94, 203 patients (167 men, 36 women) aged from 10 to 74 years (mean: 44.8 +/- 15) underwent ascending aortic replacement with composite graft for: dystrophic aneurysm (AN) (130 cases, 64.5%), chronic dissection (CD) (35 cases, 17.2%), type A acute dissection (AD) (38 cases, 18.7%). Forty-six patients (22.6%) suffered from Marfan syndrome (24 AN, 13 AD, 9 CD). Thirty patients (14.7%) had undergone a previous cardiac or aortic operation. The ascending aortic replacement was extended to the transverse arch in 28 patients (13.7%). A mechanical valve was used in 193 cases (95%). Since 1986, the ascending aorta has been totally resected and a gelatin-or collagen-coated vascular prosthesis used. The technique of coronary reattachment has varied with time and according to the aortic lesions. The classic "Bentall" technique was used in 87 patients (43%), the "button" technique in 74 (36%), the "Cabrol" technique in 26 (13%) and a "mixed" technique in 16 cases (8%). The hospital mortality rate was 7.3% (15/203) (AN: 2.3%, CD: 11.4%, AD: 21%). The only predictors of hospital death were emergency AD (P < 0.03) and arch replacement (P < 0.02). Mean follow-up was 46 +/- 10 months (2-246). The overall long-term survival rate was (Kaplan Meier) 89 +/- 6% at 1 year, 77.9 +/- 9% at 5 years, 67.7 +/- 12% at 10 years and 61.3 +/- 15% at 12 years. The 10-year survival rate is significantly higher in patients with AN (77.8 +/- 11%) than in those with AD (61.6 +/- 17%) (log. rank: P < 0.01). The late survival rate is also significantly higher after the "button" or Bentall reimplantation than after the "Cabrol" or "mixed" methods (90 +/- 5% in the "button" group and 88.7 +/- 6%, 83.8 +/- 9% and 76.6 +/- 12% in the "Bentall" group vs 80 +/- 18%, 63 +/- 21% and 58 +/- 35% in the "Cabrol" group at 1, 5 and 8 years, respectively). In conclusion, ascending aortic replacement with a composite graft is a safe procedure especially when performed electively in patients with dystrophic aneurysm or Marfan syndrome. The technique of coronary reimplantation has a significant influence on the long-term results. The reimplantation of choice is the "button" technique, especially in the presence of a fragile aortic wall (AD). The "Cabrol" technique must be used when the "button" or the "Bentall" reimplantation is not feasible, for instance during redo procedures.
从1973年4月至1994年6月,203例年龄在10至74岁(平均44.8±15岁)的患者(167例男性,36例女性)接受了升主动脉复合移植物置换术,病因如下:营养不良性动脉瘤(AN)(130例,64.5%)、慢性夹层(CD)(35例,17.2%)、A型急性夹层(AD)(38例,18.7%)。46例患者(22.6%)患有马凡综合征(24例AN,13例AD,9例CD)。30例患者(14.7%)曾接受过心脏或主动脉手术。28例患者(13.7%)的升主动脉置换术延伸至横弓。193例(95%)使用了机械瓣膜。自1986年以来,升主动脉已被完全切除,并使用了明胶或胶原涂层的血管假体。冠状动脉重新植入技术随时间和主动脉病变情况而有所不同。87例患者(43%)采用经典的“Bentall”技术,74例(36%)采用“纽扣”技术,26例(13%)采用“Cabrol”技术,16例(8%)采用“混合”技术。医院死亡率为7.3%(15/203)(AN:2.3%,CD:11.4%,AD:21%)。医院死亡的唯一预测因素是急诊AD(P<0.03)和弓部置换(P<0.02)。平均随访时间为46±10个月(2至246个月)。总体长期生存率(Kaplan-Meier法)在1年时为89±6%,5年时为77.9±9%,10年时为67.7±12%,12年时为61.3±15%。AN患者的10年生存率(77.8±11%)显著高于AD患者(61.6±17%)(对数秩检验:P<0.01)。“纽扣”或Bentall重新植入术后的晚期生存率也显著高于“Cabrol”或“混合”方法(“纽扣”组在1、5和8年时分别为90±5%,“Bentall”组为88.7±6%、83.8±9%和76.6±12%,而“Cabrol”组在相应时间分别为80±18%、63±21%和58±35%)。总之,升主动脉复合移植物置换术是一种安全的手术,尤其是在择期对营养不良性动脉瘤或马凡综合征患者进行手术时。冠状动脉重新植入技术对长期结果有显著影响。首选的重新植入技术是“纽扣”技术,尤其是在主动脉壁脆弱(AD)的情况下。当“纽扣”或“Bentall”重新植入不可行时,例如在再次手术过程中,必须使用“Cabrol”技术。